Sigma-2 receptor agonists as possible antitumor agents in resistant tumors: hints for collateral sensitivity (Q39084283)

8 September 2017

Sigma-2 receptor agonists as possible antitumor agents in resistant tumors: hints for collateral sensitivity (English)

1 reference

8 September 2017

1

1 reference

8 September 2017

2

1 reference

8 September 2017

Marialessandra Contino

3

1 reference

8 September 2017

Amalia Azzariti

5

0 references

Roberto Perrone

object named as

Roberto Perrone

6

0 references

author name string

Savina Ferorelli

4

1 reference

8 September 2017

Nicola Antonio Colabufo

7

1 reference

8 September 2017

Francesco Berardi

8

1 reference

8 September 2017

19 September 2013

1 reference

8 September 2017

1 reference

8 September 2017

8

1 reference

8 September 2017

12

1 reference

8 September 2017

2026-2035

1 reference

Pharmacology and therapeutic potential of sigma(1) receptor ligands

8 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

The sigma-1 receptor: roles in neuronal plasticity and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Sigma receptor modulators: a patent review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

σ-1 Receptors (σ1Binding Sites) Form Raft-Like Microdomains and Target Lipid Droplets on the Endoplasmic Reticulum: Roles in Endoplasmic Reticulum Lipid Compartmentalization and Export

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Is the sigma2 receptor a histone binding protein?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Sigma-2 receptors as a biomarker of proliferation in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Classes of sigma2 (σ2) receptor ligands: structure affinity relationship (SAfiR) studies and antiproliferative activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Sigma-2 ligands induce tumour cell death by multiple signalling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

2-Aminopyridine derivatives as potential σ(2) receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Arylamides hybrids of two high-affinity σ2 receptor ligands as tools for the development of PET radiotracers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Analogues of σ receptor ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) with added polar functionality and reduced lipophilicity for potential use as positron emission tomography radiotracers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

1-Cyclohexyl-4-(4-arylcyclohexyl)piperazines: Mixed σ and human Δ(8)-Δ(7) sterol isomerase ligands with antiproliferative and P-glycoprotein inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Exploring the importance of piperazine N-atoms for sigma(2) receptor affinity and activity in a series of analogs of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Synthesis and pharmacological evaluation of indole-based sigma receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Substituted benzylaminoalkylindoles with preference for the sigma2 binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Design and evaluation of naphthol- and carbazole-containing fluorescent sigma ligands as potential probes for receptor binding studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

F281, synthetic agonist of the sigma-2 receptor, induces Ca2+ efflux from the endoplasmic reticulum and mitochondria in SK-N-SH cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Inhibitors of multidrug resistance to antitumor agents (MDR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Pharmacological strategies for overcoming multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

4-(tetralin-1-yl)- and 4-(naphthalen-1-yl)alkyl derivatives of 1-cyclohexylpiperazine as sigma receptor ligands with agonist sigma2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Design, synthesis, and evaluation of new chemosensitizers in multi-drug-resistant Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

1-Cyclohexylpiperazine and 3,3-dimethylpiperidine derivatives as sigma-1 (sigma1) and sigma-2 (sigma2) receptor ligands: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Multi-drug-resistance-reverting agents: 2-aryloxazole and 2-arylthiazole derivatives as potent BCRP or MRP1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Synthesis and structure-activity evaluation of isatin-β-thiosemicarbazones with improved selective activity toward multidrug-resistant cells expressing P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Collateral sensitivity as a strategy against cancer multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Antiproliferative and cytotoxic effects of some sigma2 agonists and sigma1 antagonists in tumour cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

Cyclohexylpiperazine derivative PB28, a sigma2 agonist and sigma1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

A proposal for the classification of sigma binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

7 January 2021

Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 1. 3-(omega-aminoalkyl)-1H-indoles

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

7 January 2021

Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Strategy of Inhibiting P-Glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

7 January 2021

Measurement of cytotoxicity by ATP-based luminescence assay in primary cell cultures and cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300291

7 January 2021

Identifiers

DOI

10.1002/CMDC.201300291

1 reference

8 September 2017

1 reference